2026-08-22 · blood tests, labs, HbA1c, fasting insulin, TSH, vitamin D, ferritin, cortisol, weight loss, medical workup

What blood tests should I get before starting a weight-loss program?

The core panel is six tests: HbA1c plus fasting glucose, a lipid panel (total, LDL, HDL, triglycerides), TSH with free T4, a complete blood count (CBC), a comprehensive metabolic panel (CMP, which includes kidney function and ALT/AST liver enzymes), and 25-hydroxyvitamin D. Together they cover the fixable medical reasons weight loss commonly stalls. Add fasting insulin, ferritin, B12, testosterone, cortisol, or a PCOS panel only when your history points to them.

What blood tests should I get before starting Ozempic or Wegovy?

Ask for HbA1c (needed for type 2 diabetes coverage on Ozempic and Mounjaro), a comprehensive metabolic panel (baseline kidney function and ALT for the GLP-1 hepatic-fat trajectory), lipase or amylase as a baseline pancreatitis screen, and TSH as a baseline for medullary thyroid carcinoma counseling. Calcitonin is only indicated if you have a personal or family history of MEN2. The prescriber will usually order the panel as part of intake.

How often should I get labs while trying to lose weight?

HbA1c every 3 months in type 2 diabetes, every 6 months in prediabetes, annually in low-risk adults. Lipid panel annually if normal, every 3 to 6 months during active dyslipidemia treatment or a statin change. TSH annually if normal, every 6 weeks after any levothyroxine dose change. Vitamin D every 3 months during replacement, then annually. Over-testing is a real cost — do not chase small fluctuations in normal markers.

Do I need a fasting insulin test if my fasting glucose is normal?

Only sometimes. Fasting insulin plus HOMA-IR (a simple ratio you can calculate from fasting insulin and glucose) uncovers insulin resistance that shows up years before glucose rises — useful if you have PCOS, a strong family history of type 2 diabetes, central adiposity with normal fasting glucose, or a stalled weight-loss curve despite a real deficit. HOMA-IR above 2.5 is generally considered insulin resistant. Skip it if your history is clean and glucose is normal.

Can I order weight-loss blood tests online without a doctor?

In most US states, yes. Direct-to-consumer services (LabCorp OnDemand, Quest Direct, RequestATest, Everlywell) let you order the core panel without a prescriber for roughly $150 to $300, and the extended panel for $300 to $500. A physician on the service's side signs the requisition. The limits: interpretation is your responsibility, insurance rarely reimburses, and a lab number without a clear next step is a source of anxiety, not action.

How much do weight-loss lab panels cost without insurance in 2026?

The core 6-test panel runs $150 to $300 out of pocket at LabCorp, Quest, or a direct-to-consumer retailer in 2026. Adding the extended panel — fasting insulin, ferritin, B12, testosterone, cortisol, or a PCOS bundle — brings the total to $300 to $500. Insurance almost always covers the core panel when your visit is coded for obesity (E66.x) or the annual physical (Z00.00); high-deductible plans push most patients toward the direct-to-consumer route.

Does thyroid affect weight loss and should I always test it?

Yes, and yes — a TSH belongs in almost every weight-loss workup because untreated hypothyroidism can hold weight loss back and levothyroxine dose changes shift the numbers. The effect size is modest for typical subclinical hypothyroidism (a few pounds), but real. TSH with reflex free T4 is enough for screening; TPO antibodies are added only if TSH is high and you have a Hashimoto's-consistent picture. Retest every 6 weeks after any dose change.

What if all my blood work is normal but I still can't lose weight?

Normal labs mean the medical brakes are off — the remaining lever is behavioral. Recheck the calorie deficit itself (weighed food for one week beats any estimate), sleep (under 6 hours cuts fat loss and raises hunger), the training and step count, and any medication with weight side effects (antidepressants, antipsychotics, corticosteroids, beta-blockers, insulin). If the deficit is genuinely 500 kcal per day for a month with no scale movement, revisit TDEE assumptions before reordering labs.

Weight Loss Blood Tests: The 12 Labs to Ask Your Doctor For (2026 Guide)

The one-paragraph answer

There is no official “weight loss labs” panel, but there is a short list of tests that turn up specific fixable causes of stalled weight loss — or reasons to change your treatment plan before you start one. This page walks the full list, what the numbers mean, and what to do at each result. Bring the list to a primary-care visit or ask your telehealth GLP-1 prescriber to add them to your intake panel. If your search started with why am I not losing weight or a suspicion that your low TDEE is medical rather than behavioral, this is the workup that separates the two.

The rest of this guide is the “when to add what,” what your results mean by pattern, the 2026 US cost picture, and when to skip the PCP for a specialist.

The core panel: what almost everyone should ask for

These six sit at the foundation. Every adult starting or restarting a weight-loss plan is a candidate.

The clearest reference for the vitamin D–obesity association is Pereira-Santos 2015 (Obesity Reviews), a meta-analysis of 23 studies finding a 35 percent higher prevalence of vitamin D deficiency in adults with obesity. The clinical target and the prediabetes/diabetes thresholds come from the American Diabetes Association Standards of Care 2026 and the Endocrine Society vitamin D guideline.

The extended panel: when to add these

Add these when your history, symptoms, or a stalled weight-loss curve points to a specific cause. Ordering all of them by default is expensive, low-yield, and generates a lot of borderline numbers to interpret.

The HOMA-IR cutoff comes from the original Matthews 1985 derivation (Diabetologia). The Cushing’s workup follows the Nieman 2008 Endocrine Society guideline; testosterone criteria follow Bhasin 2018 Endocrine Society; the PCOS panel follows the Rotterdam consensus criteria (2003, 2018 update).

The GLP-1 pre-prescription panel

If you are starting semaglutide, tirzepatide, or a pipeline drug through primary care or a telehealth service, the pre-start labs are narrower than the general workup. Most prescribers order them at intake; if your service does not, ask.

• HbA1c. Required for the type 2 diabetes coverage pathway that shapes cost on Ozempic (see Ozempic vs Wegovy) and Mounjaro (see Mounjaro vs Zepbound).
• CMP. Baseline kidney function (creatinine, eGFR) and ALT for the GLP-1 hepatic-fat trajectory. GLP-1 dehydration during the escalation phase can nudge creatinine transiently.
• Lipase or amylase. Baseline pancreatitis screen. Not a routine follow-up unless symptoms appear.
• Calcitonin. Only if you have a personal or family history of multiple endocrine neoplasia type 2 (MEN2) or medullary thyroid carcinoma. The rodent thyroid C-cell signal in preclinical GLP-1 studies drives the boxed contraindication.
• TSH. Baseline for MTC contraindication counseling and for the general workup.

For the broader medication landscape and the coverage picture, see GLP-1 medications compared and prescription weight-loss medications.

The re-testing schedule

Once you have a baseline, follow-up frequency depends on the value and your treatment. Do not chase small fluctuations in normal markers — a benign wobble becomes a rabbit hole.

Weigh the trade-off. Over-testing costs money and generates borderline results whose main effect is anxiety. Under-testing misses drift. The schedule above is calibrated to the ADA Standards of Care 2026, the AACE/ATA hypothyroidism guideline (Garber 2012), and the Endocrine Society vitamin D guideline.

How to read your results — the 4 patterns

Almost every core-panel result falls into one of four patterns.

Pattern 1 — All normal. No medical brake on the lifestyle-first approach. The barrier is behavioral: the calorie deficit, sleep, protein, training, or a medication with a weight side effect. Read why am I not losing weight and revisit the numbers, not the labs.

Pattern 2 — Insulin resistance or prediabetes marker only. HbA1c 5.7–6.4% or fasting glucose 100–125 mg/dL, with an otherwise clean panel. This is the highest-leverage pattern: a 5 to 7 percent body-weight loss cuts progression to type 2 diabetes by roughly 58 percent over three years — the Knowler 2002 Diabetes Prevention Program result (NEJM). Metformin cuts progression about 31 percent by comparison.

Pattern 3 — Thyroid or hormonal marker abnormal. TSH above 4.5, low free T4, or a positive PCOS panel. Correct the underlying condition first, then re-baseline the weight trajectory. Untreated hypothyroidism will not stop weight loss entirely, but it makes the deficit feel harder and the loss slower.

Pattern 4 — Nutritional deficiency. Low ferritin, B12, or vitamin D. Correct with supplementation or dietary change before or during weight loss. A repleted patient has more energy to train, fewer sarcopenia risk factors, and (for iron and B12) better cognition and mood.

What your labs do not tell you: they do not diagnose obesity itself. Obesity is a clinical diagnosis that includes BMI, waist circumference, and comorbid conditions — a lab panel supports the workup, it does not stand in for it.

Costs and insurance reality in 2026 US

Insurance-covered path. Most primary-care visits coded with an obesity ICD-10 (E66.0, E66.9), preventive-services code (Z71.3), or annual physical (Z00.00) cover the core-panel labs on 2026 commercial and Medicare plans. Coverage of the extended panel varies by carrier — testosterone, PCOS bundles, and fasting insulin sometimes require a specific clinical indication in the chart.

Out-of-pocket range. Core panel at LabCorp, Quest, or a direct-to-consumer retailer (RequestATest, Everlywell, LabCorp OnDemand, Quest Direct) runs $150 to $300 in 2026. Adding the full extended panel brings the total to $300 to $500. Prices vary by state.

Direct-to-consumer. Legal in most US states. Useful when your clinician will not order, when you are on a high-deductible plan, or when you want a baseline before a first appointment. A physician on the retailer’s side signs the requisition. Interpretation is your responsibility. Do not order tests without a plan for what to do with the results — a lab number without a next step is a source of anxiety, not action.

Special situations — women, older adults, teens, athletes

Teens follow the adult core panel with the pediatric interpretation of ALT, lipids, and HbA1c. A pediatric endocrinology referral is warranted for HbA1c in the diabetes range or any thyroid abnormality in a growing adolescent.

What blood tests do not tell you

An honest framing, because a lot of the direct-to-consumer marketing implies more than the biology delivers.

• They do not diagnose obesity. Obesity is a clinical diagnosis (BMI, waist circumference, comorbidities). Labs support the workup.
• They do not measure metabolism directly. TSH is a rough thyroid proxy, not a measurement of resting metabolic rate. A true RMR test requires indirect calorimetry — see body composition testing for the equipment and cost.
• They do not measure body composition. That requires a DEXA, BIA, or Bod Pod scan.
• They cannot tell you which diet will work. The “personalized nutrition” companies pitching microbiome- or SNP-based diet recommendations do not have replication-quality evidence in 2026.

Labs answer specific questions about specific systems. They are not a general health score, and they do not settle the behavioral part of weight loss.

When to talk to a specialist instead of your PCP

A PCP can order almost every test on this page. The specialist visit is about interpretation and next-step decisions, not about who signs the requisition.

Practical bottom line

The right first lab panel is the core 6 tests, plus 1 to 3 additions from the extended list based on your history. Order the tests once, act on the results, and re-test only on the schedule that matches your treatment. If your clinician will not order the panel, the 2026 US direct-to-consumer market puts the core within $150 to $300 — but pair each result with a next step, or skip the test.

Sources

• Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 2002.
• American Diabetes Association. Standards of Care in Diabetes — 2026. Diabetes Care 2026.
• Garber JR et al. Clinical practice guidelines for hypothyroidism in adults (AACE/ATA). Thyroid 2012.
• Pereira-Santos M et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obesity Reviews 2015.
• Bhasin S et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2018.
• Rotterdam ESHRE/ASRM PCOS Consensus Workshop Group. Revised consensus on diagnostic criteria for PCOS (2003; 2018 update).
• Nieman LK et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008.
• Matthews DR et al. Homeostasis model assessment: insulin resistance and beta-cell function (HOMA). Diabetologia 1985.
• US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes. Updated 2024.